首页> 外文期刊>Journal of Clinical Pathology >Limited value of serum holo-transcobalamin II measurements in the differential diagnosis of macrocytosis.
【24h】

Limited value of serum holo-transcobalamin II measurements in the differential diagnosis of macrocytosis.

机译:血清全反式钴胺素II测量值在巨细胞增多症的鉴别诊断中的价值有限。

获取原文
获取原文并翻译 | 示例
       

摘要

AIM: To study the value of serum holo-transcobalamin II (holo-TCII) measurements in the differential diagnosis of macrocytosis. METHODS: Holo-TCII concentrations were measured in serum samples from 50 healthy non-vegetarian subjects and 30 patients with macrocytosis, using a technique based on the adsorption of holo-TCII with amorphous, precipitated silica. Deoxyuridine (dU) suppression tests were performed on the bone marrow cells of all the patients. Haematological diagnoses were made using standard criteria. RESULTS: The causes of macrocytosis were cobalamin (Cbl) deficiency due to pernicious anaemia or following partial gastrectomy (10 patients), dietary folate deficiency with/without Cb1 deficiency (four patients), chronic alcoholism (four patients), myelodysplastic syndrome (five patients), treatment with methotrexate or azathioprine (three patients), and congenital dyserythropoietic anaemia (CDA) (four patients). Undetectable or low holo-TCII concentrations were found in all patients with Cb1 deficiency and in some or all patients from each of the other diagnostic categories. There was also no correlation between the dU suppressed value and the holo-TCII concentration: all 15 patients with high dU suppressed values and nine of 15 with normal dU suppressed values, including four patients with CDA, had low holo-TCII concentrations. CONCLUSIONS: Measurements of serum holo-TCII concentrations by the silica adsorption method are not of value in the differential diagnosis of macrocytosis. The finding of low serum holo-TCII concentrations in patients with macrocytosis due to causes other than Cb1 deficiency may result not only from a state of negative Cb1 balance but also from other factors, such as increased utilisation of holo-TCII as a consequence of erythroid hyperplasia.
机译:目的:研究血清全反式钴胺素II(holo-TCII)测定在巨细胞增多症鉴别诊断中的价值。方法:采用基于无定形沉淀二氧化硅吸附holo-TCII的技术,从50位健康的非素食受试者和30位巨细胞增多症患者的血清样品中测量Holo-TCII的浓度。对所有患者的骨髓细胞进行了脱氧尿苷(dU)抑制试验。使用标准标准进行血液学诊断。结果:巨噬细胞增多的原因是恶性贫血或部分胃切除术后钴胺素缺乏症(10例),饮食叶酸缺乏症伴/不伴有Cb1缺乏症(4例),慢性酒精中毒(4例),骨髓增生异常综合症(5例) ),甲氨蝶呤或硫唑嘌呤治疗(3例)和先天性促红细胞生成障碍性贫血(CDA)(4例)。在所有Cb1缺乏症患者以及其他各个诊断类别的部分或全部患者中均发现无法检测到的或低水平的全面TCII浓度。 dU抑制值和holo-TCII浓度之间也没有关联:所有15例dU抑制值高的患者和15例具有dU抑制值正常的患者,包括4名CDA患者,其holo-TCII浓度低。结论:采用硅胶吸附法测定血清全血TCII浓度对巨细胞增多症的鉴别诊断没有价值。在由于Cb1缺乏症以外的原因导致巨细胞增多症患者中发现低水平的Holo-TCII浓度,不仅可能是由于Cb1平衡状态为负,还可能是由于其他因素,例如由于类红血球对holo-TCII的利用增加增生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号